These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 31910223)
41. How has the Zimbabwe mycobacterial culture and drug sensitivity testing system among re-treatment tuberculosis patients functioned during the scale-up of the Xpert MTB/RIF assay? Timire C; Takarinda KC; Harries AD; Mutunzi H; Manyame-Murwira B; Kumar AMV; Sandy C Trans R Soc Trop Med Hyg; 2018 Jun; 112(6):285-293. PubMed ID: 29992299 [TBL] [Abstract][Full Text] [Related]
42. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea. Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246 [TBL] [Abstract][Full Text] [Related]
43. Initial screening of extra-pulmonary tuberculosis using the Xpert MTB/RIF assay improves case detection rates. Jain A; Singh PK; Singh U; Kumar V Int J Tuberc Lung Dis; 2017 Apr; 21(4):478-480. PubMed ID: 28284274 [No Abstract] [Full Text] [Related]
44. A two-step algorithm for rapid diagnosis of active pulmonary tuberculosis in entry applicants using the T-SPOT.TB and Xpert MTB/RIF assays in Shanghai, China. Meng C; Shen Y; Wang J; Wang S; Chen X; Yu S; Ye W; Wu J Emerg Microbes Infect; 2017 Jul; 6(7):e67. PubMed ID: 28745310 [No Abstract] [Full Text] [Related]
45. Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis. Khalil KF; Butt T J Coll Physicians Surg Pak; 2015 Feb; 25(2):115-8. PubMed ID: 25703755 [TBL] [Abstract][Full Text] [Related]
46. Feasibility, Ease-of-Use, and Operational Characteristics of World Health Organization-Recommended Moderate-Complexity Automated Nucleic Acid Amplification Tests for the Detection of Tuberculosis and Resistance to Rifampicin and Isoniazid. David A; de Vos M; Scott L; da Silva P; Trollip A; Ruhwald M; Schumacher S; Stevens W J Mol Diagn; 2023 Jan; 25(1):46-56. PubMed ID: 36243289 [TBL] [Abstract][Full Text] [Related]
48. False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load. Ocheretina O; Byrt E; Mabou MM; Royal-Mardi G; Merveille YM; Rouzier V; Fitzgerald DW; Pape JW Diagn Microbiol Infect Dis; 2016 May; 85(1):53-5. PubMed ID: 26915638 [TBL] [Abstract][Full Text] [Related]
49. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study. Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697 [TBL] [Abstract][Full Text] [Related]
50. Coverage and fidelity of the Xpert MTB/RIF™ implementation in a high-burden area for pulmonary tuberculosis in Colombia. Agredo F; Osorio L Biomedica; 2020 Dec; 40(4):626-640. PubMed ID: 33275342 [TBL] [Abstract][Full Text] [Related]
51. [Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis in an intermediate-prevalence setting]. Ozkutuk N; Surucüoglu S Mikrobiyol Bul; 2014 Apr; 48(2):223-32. PubMed ID: 24819260 [TBL] [Abstract][Full Text] [Related]
52. The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran. Nasiri MJ; Zamani S; Pormohammad A; Feizabadi MM; Aslani HR; Amin M; Halabian R; Imani Fooladi AA Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):9-14. PubMed ID: 28823010 [TBL] [Abstract][Full Text] [Related]
53. The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection. Opota O; Mazza-Stalder J; Greub G; Jaton K Clin Microbiol Infect; 2019 Nov; 25(11):1370-1376. PubMed ID: 30928564 [TBL] [Abstract][Full Text] [Related]
54. Diagnostic performance and impact of routinely implemented Xpert® MTB/RIF assay in a setting of high incidence of drug-resistant TB in Odessa Oblast, Ukraine. Nikolayevskyy V; Kontsevaya I; Nikolaevskaya E; Surkova E; Samchenko S; Esipenko S Clin Microbiol Infect; 2019 Aug; 25(8):1040.e1-1040.e6. PubMed ID: 30590114 [TBL] [Abstract][Full Text] [Related]
55. Rapid molecular detection of pulmonary tuberculosis in HIV-infected patients in Santiago, Chile. Balcells ME; García P; Chanqueo L; Bahamondes L; Lasso M; Gallardo AM; Cifuentes L Int J Tuberc Lung Dis; 2012 Oct; 16(10):1349-53. PubMed ID: 22863872 [TBL] [Abstract][Full Text] [Related]
56. Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study. Sabi I; Rachow A; Mapamba D; Clowes P; Ntinginya NE; Sasamalo M; Kamwela L; Haraka F; Hoelscher M; Paris DH; Saathoff E; Reither K J Infect; 2018 Oct; 77(4):321-327. PubMed ID: 30036606 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia. Mavenyengwa RT; Shaduka E; Maposa I Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China. Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330 [TBL] [Abstract][Full Text] [Related]
59. Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis. Singh S; Singh A; Prajapati S; Kabra SK; Lodha R; Mukherjee A; Singh V; Hesseling AC; Grewal HM; BMC Microbiol; 2015 Sep; 15():191. PubMed ID: 26420261 [TBL] [Abstract][Full Text] [Related]
60. [Diagnosis value with Xpert Mtb/RIF assay for cervical tuberculous lymphadenitis]. Yang CQ; Liu XY; Du RH; Cao TZ; Dai XY Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 31(17):1338-1340. PubMed ID: 29798226 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]